Skip to content

Effectiveness of Oncothermia, Vitamin C based integrative oncology therapies on female breast cancer patients

Metabolic response of an integrative medicine protocol on female breast cancer patients: A prospective quasi experimental study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093448
Enrollment
37
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Mirakle Integrative Medicine protocol: The following intervention are included in the Integrative Medicine protocol: Chemotherapy (Low dose) Oncothermia High dose vitamin C therapy Oz

Sponsors

Mirakle Integrated Health Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients aged 18 years and above with a biopsy proven diagnosis of breast cancer of any stage. Also includes newly diagnosed cases as well as patients who have already undergone conventional, alternative or surgery (mastectomy / lumpectomy)

Exclusion criteria

Exclusion criteria: Patients who have psychological or cognitive illness that prevent them from given consent

Design outcomes

Primary

MeasureTime frame
Changes in the metabolic response of tumor as per PET Response Criteria in Solid Tumors (PERCIST 1.0) Changes in tumor biomarkers like CA 15.3, CEA & LDHTimepoint: 3 months, 6 months and 12 months follow up

Secondary

MeasureTime frame
Quality of life using Edmonton Symptom Assessment Scale (ESAS), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 EORTC QLQ-C30 and CPS Survival rateTimepoint: After intervention and follow up at 3, 6 & 12 months

Countries

India

Contacts

Public ContactDr Pradeep M K Nair

Mirakle Integrated Health Centre

cmo@mirakleihc.com8667483682

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026